Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bialer

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Pharmaceutical Research|December 20, 1999
Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acidO Spiegelstein, B Yagen, R H Levy, et al.
Pharmaceutical Research|April 6, 2000
Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acidO Spiegelstein, D L Kroetz, R H Levy, et al.
American Journal of Medical Genetics|September 25, 1995
Clinical spectrum in homozygotes and compound heterozygotes inheriting cystic fibrosis mutation 3849 + 10kbC > T: significance for geneticistsF Gilbert, Z Li, I I Arzimanoglou, et al.
Epilepsia|September 1, 1993
Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlationF Pisani, A Haj-Yehia, A Fazio, et al.
Neuroscience|November 20, 2012
A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticusW Pouliot, M Bialer, N Hen, et al.
Biopharmaceutics & Drug Disposition|January 1, 1994
Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatmentM Bialer, S Hadad, G Golomb, et al.
Molecular Pharmacology|December 15, 2006
The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behaviorJ A Shimshoni, E C Dalton, A Jenkins, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 29, 2006
The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humansG S J Mannens, J Hendrickx, C G M Janssen, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Pharmaceutical Research|December 20, 1999
Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acidO Spiegelstein, B Yagen, R H Levy, et al.
Pharmaceutical Research|April 6, 2000
Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acidO Spiegelstein, D L Kroetz, R H Levy, et al.
American Journal of Medical Genetics|September 25, 1995
Clinical spectrum in homozygotes and compound heterozygotes inheriting cystic fibrosis mutation 3849 + 10kbC > T: significance for geneticistsF Gilbert, Z Li, I I Arzimanoglou, et al.
Epilepsia|September 1, 1993
Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlationF Pisani, A Haj-Yehia, A Fazio, et al.
Neuroscience|November 20, 2012
A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticusW Pouliot, M Bialer, N Hen, et al.
Biopharmaceutics & Drug Disposition|January 1, 1994
Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatmentM Bialer, S Hadad, G Golomb, et al.
Molecular Pharmacology|December 15, 2006
The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behaviorJ A Shimshoni, E C Dalton, A Jenkins, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 29, 2006
The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humansG S J Mannens, J Hendrickx, C G M Janssen, et al.
Pageof 14